Ignite Creation Date:
2024-05-05 @ 6:49 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00558545
Status:
TERMINATED
Last Update Posted:
2009-12-02
First Post:
2007-11-13
Brief Title:
A Phase 1-2 XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
Sponsor:
Aegera Therapeutics
Organization:
Aegera Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-11
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-11-13
First Submit QC Date:
November 13 2007
Study First Post Date:
2007-11-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-11-30
Last Update Post Date:
2009-12-02
Last Update Post Date Type:
ESTIMATED